| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5976f86c7387fd8864fd98be85ee49b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b66fb35d61cefac3d3b1b44e2298e20f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-90241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2000-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c606f78ccd7cdd2372bf65838f9bf80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2429ad403dc3cc68914e74687722c4db |
| publicationDate |
2001-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0189581-A1 |
| titleOfInvention |
Medicinal compositions containing prostacyclin synthase gene |
| abstract |
Medicinal compositions for inducing apoptosis in cells which contain a prostacyclin synthase gene as the active ingredient; medicinal compositions for gene therapy for cancer which contain the above medicinal compositions for inducing apoptosis as the active ingredient; and a method of screening an apoptosis-inducing agent for cells characterized in that the activation of peroxisome proliferator-activated receptor-δ is determined in the presence of a test substance. By using the above-described medicinal compositions for inducing apoptosis, diseases on which therapeutic effects can be achieved by inducing apoptosis can be treated. By using the above-described medicinal compositions for gene therapy, cell death of cancer cells can be induced. By using the above-described screening method, furthermore, a drug capable of inducing apoptosis can be conveniently screened. |
| priorityDate |
2000-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |